| Front page | | Next |

Valuation of Chemical related Health Impacts

Contents

1 Dansk resumé

2 English summary

3 Introduction

4 Valuation Methodology

• 4.1 General issues related to valuation methodology
  • 4.1.1 Discounting
  • 4.1.2 Uncertainties
  • 4.1.3 Age distribution and implication on the estimates
• 4.2 Direct costs
  • 4.2.1 Methods estimation of direct costs
  • 4.2.2 Data sources
• 4.3 Individual welfare loss
  • 4.3.1 Human capital approach
  • 4.3.2 Willingness-to-pay approach
  • 4.3.3 Estimation of WTP by benefit transfer
  • 4.3.4 Valuation methodology in the present study
  • 4.3.5 The welfare loss and the disease course
  • 4.3.6 Existing data - morbidity
  • 4.3.7 Individual welfare loss in connection with mortality
  • 4.3.8 Existing data - mortality
• 4.4 Production loss
  • 4.4.1 Links to other cost components
  • 4.4.2 Production loss and age dependency
  • 4.4.3 Gross production loss estimation in the present study
  • 4.4.4 The net production loss in the present study

5 Asthma bronchiale

• 5.1 Definition
• 5.2 Chemicals associated with Asthma bronchiale
• 5.3 Disease course
• 5.4 Direct costs
  • Cost per asthmatic episode
  • Cost of diagnosis
  • Costs of daily treatment
• 5.5 Individual welfare loss
• 5.6 Production loss
• 5.7 Unit cost estimate
  • 5.7.1 Costs per asthmatic episode
  • 5.7.2 Lifetime costs

6 Headache

• 6.1 Definition
• 6.2 Chemicals associated with Headache
• 6.3 Disease course
• 6.4 Direct health care costs
  • Costs of an acute episode
  • Cost of establishing the diagnosis
• 6.5 Individual welfare Loss
• 6.6 Production loss
• 6.7 Unit cost estimate

7 Contact Allergy

• 7.1 Definition
• 7.2 Chemicals associated with contact allergy
• 7.3 Disease course
• 7.4 Direct health care costs
  • Diagnosis
  • Daily treatment for contact allergy
• 7.5 Individual welfare loss
• 7.6 Production loss
• 7.7 Unit cost estimate
• 7.8 Example of unit cost application: Nickel Allergy
  • 7.8.1 Scenario definition
  • 7.8.2 Mapping of impacts
  • 7.8.3 Valuation of impacts

8 Lung cancer

• 8.1 Definition
• 8.2 Chemicals associated with Lung Cancer
• 8.3 Disease course
• 8.4 Direct health care costs
  • Cost of hospital and primary care
  • Cost of terminal care
• 8.5 Individual welfare Loss
• 8.6 Production loss
• 8.7 Unit cost estimate

9 Skin cancer

• 9.1 Definition
• 9.2 Chemicals associated with Skin Cancer
• 9.3 Direct health care costs
  • Costs for patients treated in the hospital sector
• 9.4 Individual welfare loss
• 9.5 Production loss
• 9.6 Unit cost estimate

10 Unit costs - summary of results

• 10.1 Summary of results
• 10.2 Uncertainties - Low and high unit cost estimates
  • 10.2.1 Identification of critical elements
  • 10.2.2 Assessment of low and high values
• 10.3 Concluding remarks

11 References

Appendix 1. List of sources for the direct cost calculations

Appendix 2. Resource persons

• Asthma
• Contact allergy
• Headache
• Lung cancer
• Skin cancer

Appendix 3. Glossary

| Front page | | Next | | Top |

Version 1.0 June 2004, © Danish Environmental Protection Agency